Settlement of the CR is likely to occur today according to the announcement. Therefore the recent selling could well be attributed to existing holders raise fund and re-balance their portfolios for the settlement. The drop in SP seems logical and normal.
The EFS trial is about to start this month. If the recruitment goes well and the results are good, our competitors could be very worried as each recruited patient could translate to not just the lost revenue to them now but well into the future potentially.
Not advice, DYOR
Ann: $35M Capital Raise, page-139
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.30 |
Change
-0.650(5.44%) |
Mkt cap ! $238.8M | |||
| Open | High | Low | Value | Volume |
| $11.71 | $11.83 | $11.24 | $346.8K | 29.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $11.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.50 | 50 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |